Table 2.
Characteristics of the patients
| Characteristic | N=905 N (%) |
|---|---|
| Male, n (%) | 575 (63.5) |
| Mean age, years (SD) | 62.1 (7.9) |
| Body mass index, kg/m² (SD) | 30.7 (5.2) |
| Mean systolic blood pressure, mm Hg (SD)* | 145.9 (15.3) |
| Mean diastolic blood pressure, mm Hg (SD)* | 83.7 (11.7) |
| LDL, mmol/L (SD) | 3.19 (1.02) |
| MDRD-estimated glomerular filtration rate, mL/min (SD) | 79.6 (19.6) |
| Left ventricular hypertrophy, n (%) | 150 (16.6) |
| Family history of early cardiovascular event, n (%) | 225 (24.9) |
| Albuminuria ≥20 mg/L, n (%) | 186 (22.3) |
| Mean years since diagnosis of hypertension (SD) | 10.5 (7.8) |
| Smoker status | |
| Current n (%) | 193 (21.3) |
| Past smoker <3 years n (%) | 72 (8.0) |
| Non-smoker n (%) | 640 (70.7) |
| Number of antihypertensive drugs, n (SD) | 2.16 (1.04) |
| Type 2 diabetes, n (%) | 527 (58.2) |
| Mean years since diagnosis of type 2 diabetes (SD) | 6.9 (6.1) |
| HbA1c, % (SD) | 7.0 (1.1) |
| Cardiovascular risk factors, n (%) | |
| Men >50 or women >60 years | 779 (86.1) |
| Current smoker or past smoker <3 years | 265 (29.3) |
| LDL≥4.14 mmol/L or treatment | 692 (76.5) |
| HDL≤1.04 mmol/L | 189 (20.9) |
| Number of cardiovascular risk factors, n (%) | |
| ≤2 | 259 (28.6) |
| 3 | 319 (35.2) |
| 4 | 222 (24.5) |
| ≥5 | 105 (11.6) |
| Mean 10-year Framingham-Anderson risk score (%) | 17.5 |
HbA1c, haemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MDRD, modification of diet in renal disease.